-
Mashup Score: 1Adjuvant Treatment for Endometrial Cancer - Expert Perspectives - 16 hour(s) ago
expert roundtables by David Scott Miller, MD, FACOG, FACS; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Pamela T. Soliman, MD, MPH Following surgery for intermediate- to high-risk endometrial cancer, clinicians and patients carefully weigh the risks and benefits of adjuvant therapies. Tumor characteristics used to guide treatment selection for advanced and recurrent endometrial cancer may eventually have a role in the selection of adjuvant therapy. “I tell patients that we could potentially reduce the
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Faith-based cost-sharing seemed like an alternative to health insurance, until the childbirth bills arrived - 2 day(s) ago
Health care sharing ministries advertise reimbursements for members’ medical bills. But they are largely unregulated, and most have restrictions on maternity coverage.
Source: apple.newsCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7
David S. Miller, MD, discusses the efficacy of selinexor in patients with advanced or recurrent TP53 wild-type endometrial cancer.
Source: www.onclive.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3581
MADISON, WI—In the hours following a violent rampage in Wisconsin in which a lone attacker killed at least two individuals and injured six others, citizens living in the only country where this kind of mass killing routinely occurs reportedly concluded Monday that there was no way to prevent the massacre from taking place. “This was […]
Source: theonion.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Expert Roundtables Podcast: The Use of Biomarkers in the Management of Endometrial Cancer - Expert Perspectives - 12 day(s) ago
expert roundtables by David Scott Miller, MD, FACOG, FACS; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Pamela T. Soliman, MD, MPH When combined with histological characteristics, molecular biomarkers support a personalized treatment approach for endometrial cancer. Selecting treatments based on a patient’s biomarkers may help to not only maximize treatment benefits but also prevent treatment-related toxicities in patients whose endometrial cancer is unlikely to respond to the therapies. Our featured
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0My Thoughts On The United Healthcare CEO Murder - 14 day(s) ago
UPDATE: Since recording this video, an arrest has been made (NOT JIMOTHY) and BCBS completely rescinded their proposed anesthesia policy!Also, I hinted at wa…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Once called “America’s Doctor,” Donald Trump’s pick to head Medicare is now more known for dubious promotion of supplements and hormones unsupported by scientific evidence.
Source: www.nbcnews.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1The Day John Kennedy Died -- Lou Reed - YouTube Music - 1 month(s) ago
The Day John Kennedy Died by Lou Reed
Source: music.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7
David S. Miller, MD, discusses the efficacy of selinexor in patients with advanced or recurrent TP53 wild-type endometrial cancer.
Source: www.onclive.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0The Maternal Mortality Rate Surged in Texas in 2020 and 2021 - 3 month(s) ago
The spike reversed two years of improvement.
Source: www.texasmonthly.comCategories: General Medicine News, Oncologists1Tweet
Adjuvant Treatment for Endometrial Cancer with Drs. Alex Olawaiye & @PamSolimanMD . From @eponcology. #gyncsm #endometrialcancer #adjuvant https://t.co/OrZsHeBNjL